Sedana Medical AB (SEDANA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Sedana Medical AB (SEDANA) has a cash flow conversion efficiency ratio of -0.006x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.25 Million ≈ $-564.55K USD) by net assets (Skr900.78 Million ≈ $96.94 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review financial flexibility index of Sedana Medical AB to assess the company's free cash flow relative to its total liabilities.
Sedana Medical AB - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Sedana Medical AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Sedana Medical AB (SEDANA) total market value for the company's overall valuation and market capitalisation.
Sedana Medical AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Sedana Medical AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Action Electronics Co Ltd
TW:3024
|
-0.039x |
|
CJ CheilJedang Corp
KO:097955
|
0.068x |
|
Wellspire Holdings Berhad
KLSE:0271
|
-0.129x |
|
Shree Digvijay Cement Co.Ltd
NSE:SHREDIGCEM
|
-0.145x |
|
GRP Limited
NSE:GRPLTD
|
0.098x |
|
ELEMENT 29 RESOURCES INC
F:2IK
|
-0.018x |
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
0.023x |
|
Mangata Holding S.A.
WAR:MGT
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Sedana Medical AB (2016–2025)
The table below shows the annual cash flow conversion efficiency of Sedana Medical AB from 2016 to 2025. View Sedana Medical AB (SEDANA) share price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr900.78 Million ≈ $96.94 Million |
Skr-12.78 Million ≈ $-1.38 Million |
-0.014x | -15.51% |
| 2024-12-31 | Skr958.23 Million ≈ $103.12 Million |
Skr-11.77 Million ≈ $-1.27 Million |
-0.012x | +68.70% |
| 2023-12-31 | Skr970.00 Million ≈ $104.39 Million |
Skr-38.06 Million ≈ $-4.10 Million |
-0.039x | +65.02% |
| 2022-12-31 | Skr1.03 Billion ≈ $110.75 Million |
Skr-115.43 Million ≈ $-12.42 Million |
-0.112x | -199.71% |
| 2021-12-31 | Skr1.10 Billion ≈ $118.53 Million |
Skr-41.22 Million ≈ $-4.44 Million |
-0.037x | -162.86% |
| 2020-12-31 | Skr551.09 Million ≈ $59.31 Million |
Skr-7.85 Million ≈ $-844.35K |
-0.014x | +6.83% |
| 2019-12-31 | Skr569.38 Million ≈ $61.27 Million |
Skr-8.70 Million ≈ $-936.28K |
-0.015x | +42.41% |
| 2018-12-31 | Skr217.81 Million ≈ $23.44 Million |
Skr-5.78 Million ≈ $-621.90K |
-0.027x | -723.16% |
| 2017-12-31 | Skr116.40 Million ≈ $12.53 Million |
Skr495.60K ≈ $53.33K |
0.004x | -97.74% |
| 2016-12-31 | Skr1.26 Million ≈ $135.81K |
Skr238.00K ≈ $25.61K |
0.189x | -- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more